International Stem Cell Co. (OTCMKTS:ISCO) Short Interest Up 3,000.0% in May

International Stem Cell Co. (OTCMKTS:ISCO) was the recipient of a large growth in short interest in the month of May. As of May 31st, there was short interest totalling 3,100 shares, a growth of 3,000.0% from the May 15th total of 100 shares. Based on an average daily volume of 9,400 shares, the short-interest ratio is currently 0.3 days. Approximately 0.2% of the shares of the company are sold short.

International Stem Cell Stock Down 7.6%

Shares of OTCMKTS:ISCO opened at $0.12 on Thursday. The firm’s 50 day moving average price is $0.12 and its 200-day moving average price is $0.11. International Stem Cell has a twelve month low of $0.05 and a twelve month high of $0.20. The stock has a market capitalization of $961,280.40, a PE ratio of -1.50 and a beta of -0.22.

International Stem Cell (OTCMKTS:ISCO) last issued its quarterly earnings data on Wednesday, May 14th. The biotechnology company reported ($0.03) earnings per share for the quarter. The firm had revenue of $2.13 million for the quarter.

International Stem Cell Company Profile

International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.